EGFR and hereditary clear cell renal cell carcinoma: As shown in Figure 5, patients in the low-risk group mainly involved in the ERBB signaling pathway, MAPK signaling pathway, MTOR signaling pathway, WNT signaling pathway, insulin signaling pathway, and renal cell carcinoma pathway, etc.